Document is current
Any future updates will be listed below
-
Authors
Li, Xiangmei
Pan, Bingyue
He, Yalan
Wang, Ziyi
Tang, Yujie
Zhang, Yongbao
Wang, Liqiang
Han, Junwei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (62372143)
Natural Science Foundation of Heilongjiang Province (LH2019C042)
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 21 November 2025
First Online: 2 December 2025
Declarations
:
: This study utilized exclusively pre-existing, de-identified data from the cBioPortal for Cancer Genomics ( ). All data were accessed and analyzed in accordance with the cBioPortal’s terms of use. In compliance with the official policy of the Harbin Medical University Institutional Review Board (IRB)/Ethics Committee, this research, which involves the secondary analysis of such publicly available, non-identifiable data, is not classified as human subjects research and therefore did not require separate ethical approval from the committee. The original primary studies that contributed data to cBioPortal were conducted in accordance with the ethical standards of the World Medical Association’s Declaration of Helsinki, including the procurement of informed consent from their respective participants. Our secondary analysis adhered to the ethical principles governing the use of such data.
: Not applicable.
: The authors declare no competing interests.
